Advertisement
Loading...

Merck & Co., Inc.

MRK•NYSE
Healthcare
Drug Manufacturers - General
$111.38
$-2.03(-1.79%)
U.S. Market opens in 26h 56m

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap275.1B
P/E Ratio30.81
EPS (TTM)$3.55
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$108.17
3 Months$108.54
1 Year Target$136.48

MRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merck & Co., Inc. (MRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $136.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.81 and a market capitalization of 275.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.78%
5-Day Change
-0.88%
1-Month Change
-5.52%
3-Month Change
-8.25%
6-Month Change
19.88%
Year-to-Date (YTD) Change
5.82%
1-Year Change
48.92%
3-Year Change
-4.28%
5-Year Change
46.26%
All-Time (Max) Change
28073.61%

Contact Information

https://www.merck.com
908 740 4000
126 East Lincoln Avenue, Rahway, NJ, 07065

Company Facts

73,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions